Selatogrel: A Novel Subcutaneous P2Y12 Inhibitor. Beavers CJ, Effoe SA, Dobesh PP. J Cardiovasc Pharmacol 2022;79:161-167.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Beavers CJ, Effoe SA, Dobesh PP. Selatogrel: A Novel Subcutaneous P2Y12 Inhibitor. J Cardiovasc Pharmacol 2022;79:161-167.
PMID: 34132688